Results of a phase I/II single arm clinical trial assessing efficacy, safety and tolerability of the recombinant Bacillus Calmette Guerin VPM1002BC in patients with non-muscle invasive bladder cancer recurrence after BCG induction with or without BCG maintenance therapy - SAKK 06/14

Rentsch, Cyrill A. and Thalmann, George N. and Ilaria, Lucca and Kwiatkowski, Maciej and Wirth, Gregory J. and Strebel, Raeto T. and Engeler, Daniel and Pedrazzini, Augusto and Huettenbrink, Clemens and Schultze-Seemann, Wolfgang and Torpai, Raimund and Bubendorf, Lukas and Wicki, Andreas and Roth, Beat and Bosshard, Piet and Pueschel, Heike and Boll, Daniel and Hefermehl, Lukas and Roghmann, Florian and Gierth, Michael and Ribi, Karin and Schaefer, Simon and Hayoz, Stefanie (2020) Results of a phase I/II single arm clinical trial assessing efficacy, safety and tolerability of the recombinant Bacillus Calmette Guerin VPM1002BC in patients with non-muscle invasive bladder cancer recurrence after BCG induction with or without BCG maintenance therapy - SAKK 06/14. In: International Bladder Cancer Network (IBCN), October 17, 2020.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (UNSPECIFIED)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Urologie
Depositing User:	Petra Gürster
Date Deposited:	21 Apr 2021 10:10
Last Modified:	21 Apr 2021 10:12
URI:	https://pred.uni-regensburg.de/id/eprint/43255

Actions (login required)

View Item